Compromising Outcomes.
作者信息
Imrey Peter B
机构信息
Department of Quantitative Health Sciences, Lerner Research Institute and
Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio; and
出版信息
J Am Soc Nephrol. 2019 Jul;30(7):1147-1150. doi: 10.1681/ASN.2019010057. Epub 2019 Jun 17.
Abstract
摘要
相似文献
1
Compromising Outcomes.
J Am Soc Nephrol. 2019 Jul;30(7):1147-1150. doi: 10.1681/ASN.2019010057. Epub 2019 Jun 17.
2
[Biomedical tests outside the nomenclature in France: what are the priorities in nephrology?].
Ann Biol Clin (Paris). 2019 Aug 1;77(4):368-370. doi: 10.1684/abc.2019.1457.
3
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.
Kidney Int. 2014 Jan;85(1):23-30. doi: 10.1038/ki.2013.391. Epub 2013 Oct 2.
4
p-Hacking and publication bias interact to distort meta-analytic effect size estimates.
Psychol Methods. 2020 Aug;25(4):456-471. doi: 10.1037/met0000246. Epub 2019 Dec 2.
5
Nephrology: As It Was Then, But Is Not Now.
Am J Kidney Dis. 2017 Jan;69(1):129-135. doi: 10.1053/j.ajkd.2016.06.029. Epub 2016 Oct 15.
6
A new initiative in nephrology: 'Kidney disease: improving global outcomes'.
Contrib Nephrol. 2005;149:90-99. doi: 10.1159/000085462.
7
The ethics of genetic testing for kidney diseases.
Nat Rev Nephrol. 2020 Nov;16(11):619-620. doi: 10.1038/s41581-020-0294-5. Epub 2020 May 1.
8
Nephrology research output in Iran in a decade.
Iran J Kidney Dis. 2007 Oct;1(2):57-62.
9
Latin American nephrology: scientific production and impact of the publications.
Kidney Int. 1999 Oct;56(4):1584-90. doi: 10.1046/j.1523-1755.1999.00681.x.
10
[What is new in pediatric nephrology?].
Arch Pediatr. 2006 Jan;13(1):64-8. doi: 10.1016/j.arcped.2005.10.009. Epub 2005 Nov 28.
引用本文的文献
1
Cardiac Magnetic Resonance Imaging Findings in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Systematic Review.
ACR Open Rheumatol. 2025 Apr;7(4):e70026. doi: 10.1002/acr2.70026.
本文引用的文献
1
Quantity and Reporting Quality of Kidney Research.
J Am Soc Nephrol. 2019 Jan;30(1):13-22. doi: 10.1681/ASN.2018050515. Epub 2018 Dec 13.
2
Registration and Outcome-Reporting Bias in Randomized Controlled Trials of Distal Radial Fracture Treatment.
JB JS Open Access. 2018 Jul 24;3(3):e0065. doi: 10.2106/JBJS.OA.17.00065. eCollection 2018 Sep 25.
3
Influence of peer review on the reporting of primary outcome(s) and statistical analyses of randomised trials.
Trials. 2018 Jan 11;19(1):30. doi: 10.1186/s13063-017-2395-4.
4
Editorial: Multiplicity issues in clinical trials.
Stat Med. 2017 Dec 10;36(28):4423-4426. doi: 10.1002/sim.7506.
5
Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs.
Transl Psychiatry. 2017 Sep 12;7(9):e1232. doi: 10.1038/tp.2017.203.
6
Multiplicity considerations in subgroup analysis.
Stat Med. 2017 Dec 10;36(28):4446-4454. doi: 10.1002/sim.7416. Epub 2017 Aug 1.
7
Changes are still needed on multiple co-primary endpoints.
Stat Med. 2017 Dec 10;36(28):4427-4436. doi: 10.1002/sim.7383. Epub 2017 Jul 19.
8
Comparison of Registered and Reported Outcomes in Randomized Clinical Trials Published in Anesthesiology Journals.
Anesth Analg. 2017 Oct;125(4):1292-1300. doi: 10.1213/ANE.0000000000002272.
9
Composite and multicomponent end points in clinical trials.
Stat Med. 2017 Dec 10;36(28):4437-4440. doi: 10.1002/sim.7386. Epub 2017 Jul 4.
10
Some remaining challenges regarding multiple endpoints in clinical trials.
Stat Med. 2017 Dec 10;36(28):4441-4445. doi: 10.1002/sim.7390. Epub 2017 Jun 30.
Zotero 插件